参考文献
［1］中国结直肠癌诊疗规范（2020年版）.中国实用外科杂志，2020，40（06）：601-625.
［2］中国临床肿瘤学会指南工作委员会.中国临床肿瘤学会（CSCO）结直肠癌诊疗指南2020.人民卫生出版社，2020：1-290.
［3］Chen W，Zheng R，Baade PD，et al.Cancer statistics in China，2015.CA Cancer J Clin.2016，66（2）：115-132.
［4］Miller KD，Goding Sauer A，Ortiz AP，et al.Cancer Statistics for Hispanics/Latinos，2018.CA Cancer J Clin.2018，68（6）：425-445.
［5］Her nandez R K，Wade S W，Ly man GH，et al.I ncidence of bone metastases in patients with solid tumors：analysis of oncology electronic medical records in the United States.BMC Cancer.2018，18（1）：44.
［6］Stecco A，Trisoglio A，Soligo E，et al.Whole-body MRI with diffusion weighted imaging in bone metastases：a narrative review.Diagnostics（Basel）.2018，8（3）：pii：E45.
［7］Planchard D，Popat S，Kerr K，et al.Metastatic non-small cell lung cancer：ESMO Clinical Practice Guidelines for diagnosis，treatment and follow-up.Ann Oncol.2018，29（Supplement_4）：ⅳ192-iv237.
［8］Miranda J，VialD，Pinto.Radium 223 for the treatment of metastatic castration-resistant prostate cancer.Arch Esp Urol.2019，72（5）：500-507.
［9］Wang Z，Wang X，Yuan J，et al.Survival benefifit of palliative local treatments and efficacy of diferent pharmacotherapies in colorectal cancer with lung metastasis：results from a large retrospective study.Clin Colorectal Cancer.2018，17（2）：e233-e255.
［10］陈万青，李贺，孙可欣，等.2014年中国恶性肿瘤发病和死亡分析.中华肿瘤杂志.2018，040（001）：5-13.
［11］Zeng H，ZhengR，GuoY，etal.Cancer survival in China，2003-2005：a population-based study.Int J Cancer.2015，136（8）：1921-30.
［12］Samarin A，Hüllner M，Queiroz MA，et al.18F-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with 18F-FDG-PET/CT.Nucl Med Commun.2015，36（12）：1165-1173.
［13］Planchard D，Popat S，Kerr K.Metastatic non-small cell lung cancer：ESMO Clinical Practice Guidelines for diagnosis，treatment and followup.Ann Oncol.2019.
［14］HimelsteinAL，QinR，NovotnyPJ，etal.CALGB 70604（Alliance）：A randomized phase Ⅲ study of standard dosing vs.longer interval dosing of zoledronic acid in metastatic cancer.JClin Oncol.2015，33（15）：9501.
［15］Lecouvet FE，Talbot JN，Messiou C，et al.Monitoring the response of bone metastases to treatment with magnetic resonance imaging and nuclear medicine techniques：A review and position statement by the European Organisation for Research and Treatment of Cancer imaging group.Eur J Cancer.2014，50（15）：2519-2531.(https://www.daowen.com)
［16］韩苏军，张思维，陈万青，等.中国前列腺癌发病现状和流行趋势分析.临床肿瘤学杂志.2013，018（004）：330-334.
［17］Bayne，Christopher E.Stephen H.Culp，Paul F.Schellhammer，et al.Williams.Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the PrimaryTumor？A SEER-based Study.Eur Urol.2014，65：1058-66.
［18］Siegel R L，Miller K D，Jemal A.Cancer statistics，2018.Ca A Cancer Journal for Clinicians.2018，68（1）：7.
［19］SpahnM，Joniau S，Gontero P，et al.Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen GreaterThan 20 ng/ml：A European Multi-Institutional Study of 712 Patients.European Urology.2010，58（1）：1-7.
［20］Horwitz EM，Bae K，Hanks GE，et al.Ten-year follow-up of radiation therapy oncology group protocol 92-02：a phase Ⅲtrial of the duration of elective androgen deprivation in locally advanced prostate cancer.J Clin Oncol.2008，26（15）：2497-2504.
［21］FizaziK，CarducciM，SmithM，etal.Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer：arandomised，double-blind study.Lancet.2011，377（9768）：813-22.
［22］FaienaI，Salmasi A，Pantuck A J，et al.Re：Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.European Urology.2018：S0302283818300770.
［23］肾癌骨转移专家共识（2020版）.中华肿瘤杂志.2020，42（07）：537-542.
［24］中国临床肿瘤学会指南工作委员会.中国临床肿瘤学会（CSCO）肾癌诊疗指南2020.人民卫生出版社.2020：1-96.
［25］Yoshimura A，NakataW，Yamamichi G，et al.Complete remission of metastatic renal cell carcinoma to the bone with sunitinib.Urol Case Rep.2020.32：101213.
［26］Jeremy Setton，JamesHan，DanitaKannarunimit，etal.Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma.oral oncology.2016，53：67-73.
［27］Li XY，JiaGD，SunXS，etal.Intensive Local Radiotherapy Is Associated With Better Local Control and Prolonged Survival in Bone-Metastatic Nasopharyngeal Carcinoma Patients.Front Oncol.2020，10：378.
［28］Guo Q，ChenM，XuH，etal.Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy：A Single-Institution Experience.CancerManag Res.2020，12：1387-1396.
［29］刘正，许宋锋，刘恩瑞，等.中国结直肠癌骨转移多学科综合治疗专家共识（2020版）.中华结直肠疾病电子杂志。2020，9（03）：217-221.
［30］Tampellini M，Ottone A，Bellini E，et al.The role of lung metastasis resection in improving outcome of colorectal cancer patients：results from a large retrospective study.Oncologist.2012，17（11）：1430-1438.